…coronary stent implantation. ACS is associated with a high risk of platelet driven atherothrombosis, while interruption of antiplatelet therapy after recent stenting is associated with…

…stents (BMS) in response to restenosis caused principally by neointimal hyperplasia. Contemporary DES combine a metallic scaffold, a polymeric or polymer free drug delivery system…

…treatment with aspirin plus a P2Y12 receptor inhibitor. In the setting of acute coronary syndrome (ACS), DAPT is used to reduce recurrent myocardial infarction, stent…

…cardiovascular death, and progression of atherosclerotic disease in patients with established coronary or other atherosclerotic vascular disease. Antiplatelet therapy is a central component because platelet…

…4a MI: Represents a periprocedural myocardial infarction associated with percutaneous coronary intervention (PCI). Type 4b MI: Denotes myocardial infarction related to stent thrombosis following PCI…

…percutaneous coronary intervention (PCI) Type 4b MI caused by stent or scaffold thrombosis Type 4c MI caused by restenosis Type 5 MI associated with coronary…

…fulfilled. The temporal relationship to stent implantation should always be specified. Coronary arterial thrombi are predominantly platelet rich because they form under high shear conditions…

…percutaneous coronary intervention (PCI). In contemporary practice, ISR remains the most frequent cause of PCI failure, despite its substantially lower incidence with drug eluting stents…

…injury Procedural injury may result from acute compromise of coronary flow. Mechanisms include: Coronary dissection with obstruction of the true lumen Occlusion of a major…

…the system, compared with roughly 70–200 µm for gray scale IVUS. This allows detailed visualization of the lumen surface, fibrous cap thickness, thrombus, stent…